In contrast, TP53, CDKN2A, and SMAD4 mutations are more common with high-grade dysplasia (HGD), supporting their role in risk stratification for IPMN progression to invasive tumors [52, 54]. Here, TP53 is linked to pancreatic intraductal papillary-mucinous neoplasm.